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We describe structure-activity relationships that
emerged frombiophysicaldataobtainedwitha library
of antimicrobial peptide mimetics composed of 103
oligoacyllysines (OAKs) designed to pin down the im-
portance of hydrophobicity (H) and charge (Q). Based
on results obtained with OAKs displaying minimal
inhibitory concentration % 3 mM, the data indicate
that potent inhibitory activity of the gram-negative
Escherichia coli and the gram-positive Staphylococ-
cus aureus required a relatively narrow yet distinct
window of HQ values where the acyl length played
multiple andcritical roles, both inmolecular organiza-
tion and in selective activity. Thus, incorporation of
long—but not short—acyl chains within a peptide
backbone is shown to lead to rigid supramolecular or-
ganization responsible for poor antibacterial activity
andenhancedhemolytic activity.However, sequence
manipulations, including introduction of a tandem
lysinemotif into the oligomer backbone, enabled dis-
assembly of aggregated OAKs and subsequently
revealed tiny, nonhemolytic, yet potent antibacterial
derivatives.
INTRODUCTION
The success of infectious disease chemotherapy has been
dimmed ever since the dawn of the antimicrobial drug era
because of antibiotic resistance (Weber and Courvalin, 2005;
MacKenzie et al., 2005). Today, because of the emergence of
resistant organisms (Roos, 2004; Cookson, 2005), numerous
diseases are becoming increasingly difficult to treat, including
microorganisms responsible for severe infections in hospitalized
patients, food-borne pathogens, and sexually transmitted patho-
gens, some of which are now resistant to most available antimi-
crobial drugs (Paterson, 2006; Rice, 2006; White et al., 2002).
The clinical impact of resistance is immense, characterized by
increased cost, morbidity, and mortality (Cassell, 1997; Howard
et al., 2003), hence the importance of developing new antimicro-
bial agents (Bush, 2004). Due to exhausting efforts in the past 2
decades, low molecular weight peptide-based compounds,
termed host defense peptides (HDPs) are increasingly recog-
nized as a potential source for new antimicrobial agents (Zasloff,
2002; Jenssen et al., 2006). HDPs are products of evolutionary354 Chemistry & Biology 15, 354–362, April 2008 ª2008 Elsevier Ltddevelopment, and their sequences and activities have been
exquisitely refined by nature (Tennessen, 2005). Unfortunately,
HDPs, per se, do not represent ideal drug candidates because
of drawbacks, such as reduced activity in the presence of salt,
divalent cations, pH (Goldman et al., 1997; Lee et al., 1997;
Minahk and Morero, 2003), plasma components, and proteases
(Radzishevsky et al., 2005; Rozek et al., 2003), and because of
poorpharmacokinetic (PK) issues,highsystemic toxicity, andhigh
production costs (Bradshaw, 2003; Gordon et al., 2005). Clearly,
unless these concerns are properly addressed, the promise of
HDPs as a new class of therapeutic agents will remain elusive.
To ameliorate the characteristic disadvantages, various syn-
thetic peptide-mimetics that reproduce critical HDPs biophysi-
cal characteristics, such as cationicity, hydrophobicity (H), and
amphipathicity in unnatural, sequence-specific oligomers, have
been proposed (Patch and Barron, 2002). Generally, these
HDP-mimetics are derived from a lead peptide sequence, where
structural modifications have been incorporated to improve
activity and/or metabolic resilience (Latham, 1999; Adessi and
Soto, 2002). Examples of HDP-peptidomimetics include b pep-
tides and peptoids, designed to mimic the overall physicochem-
ical properties of antimicrobial peptides and shown to have char-
acteristic secondary structures in lipid vesicles and/or in buffer.
b peptides are a class of polyamides that adopt helical structures
with conformational freedom greater than a peptides, because
of the additional methylene unit present in the polymer backbone
(Liu and DeGrado, 2001; Porter et al., 2002). Several b peptides
were designed to mimic magainin and cecropin and were shown
to have potent antimicrobial activity, including, however, signifi-
cant activity against human erythrocytes (Liu and DeGrado,
2001). Several peptoids, oligomers of N-substituted glycines,
also have stable secondary structure, despite the achirality of the
polymer backbone and lack of hydrogen bond donors (Kirshen-
baum et al., 1998). Certain peptoids were reported to exhibit
nonhemolytic, potent antibacterial activity against both gram-
positive and gram-negative bacteria (Patch and Barron, 2003).
Another example is represented by facially amphiphilic aryla-
mide polymers (Tew et al., 2002), representing another strategy
to produce inexpensive synthetic polymers with broad-spectrum
antibacterial activity. Regardless of these efforts and despite
numerous clinical trials, no natural or modified peptide has yet
obtained Food and Drug Administration approval for any (topical
or systemic) medical indications (Jenssen et al., 2006).
Previous studies aimed at understanding HDPs’ mechanism
of action have pointed to probable target sites and stressed
the significance of secondary structure. However, as HDPs con-
tain neither a consensus sequence nor a common secondaryAll rights reserved
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hydrophobic and positively charged amino acids), it was recently
proposed that secondary structure is not required for potent
antimicrobial activity (Schmitt et al., 2007; Ilker et al., 2004;
Oren and Shai, 1997). This proposal was recently verified with
new HDP-mimetic olygomers based on acyl-lysine (AK) subunits
(referred to as an subunits), which were designed to inhibit
formation of defined secondary structures (Radzishevsky et al.,
2007a, 2007b). In a preliminary series of 16 oligoacyllysines
(OAKs) composed of aminobutyryl-lysine (a4) or aminooctanoyl-
lysine (a8) subunits, two octameric OAKs revealed potent anti-
bacterial properties, both in vitro and in vivo. Moreover, the data
suggested that OAKs design may facilitate the dissection of the
relative roles of charge (Q) and H, the parameters believed to be
most crucial to the activity of antimicrobial peptides.
To verify this claim, we extended the OAK library to include a
total of 103 compounds intended to assess the role of composi-
tion and of sequence on antimicrobial properties. Thus, the initial
group of 16 published sequenceswas extended to include a total
of 56 OAKs based on a4 or a8 subunits. An additional 27 OAKs
based on a12 subunits were investigated to further pin down
the role of acyl length. Analysis of these compounds (collectively
termed a-OAKs) inspired the design of 20 additional OAKs com-
posed of b12 (lysyl-aminododecanoyl-lysyl) subunits designed
to address the importance of sequence. The basic structure of
typical a- and b-OAKs is shown in Figure 1. The overall data anal-
ysis enabled us to draw pertinent conclusions with respect to
physicochemical properties required for potency and/or selec-
tivity of OAKs.
RESULTS AND DISCUSSION
Properties of a-OAKs
An initial library of 83 a-OAKs was prepared and screened for
various biophysical properties (see Table S1 in the Supplemental
Data available with this article online). The library included vari-
ous subseries designed to assess the importance of Q and H
by systematically modifying the number of a subunits (up to
10) and the acyl length (4, 8, or 12 carbon atoms), respectively.
The table lists the minimum inhibitory concentration (MIC) value
of each OAK, determined against two representative bacteria
(gram-negative Escherichia coli and gram-positive, methicillin-
resistant Staphylococcus aureus) and the hemolytic activity
determined against human red blood cells (RBC). The structure-
activity relationships (SARs) that emerged from this library can
Figure 1. Molecular Structures of Typical
OAKs
Parentheses point to a12 (aminododecanoyl-lysyl)
and b12 (lysyl-aminododecanoyl-lysyl) subunits
composing a representative a-OAK, C12K-2a12
and a representative b-OAK, C12K-2b12 (upper and
lower structures, respectively).
be summarized as follows. Relatively few
members of this library displayed the
ability to inhibit bacterial growth, prefera-
bly of E. coli. The butyryl- and octanoyl-
based series displayed activity at H R
45% when Q R 5, and were characteristically nonhemolytic.
The dodecanoyl-based OAKs, however, displayed antibacterial
activity already in the dimer C12K-a12 (H = 56; Q = 2), which was
also mildly hemolytic, while all longer derivatives were inactive
against bacteria (MIC > 50 mM), but displayed a strong hemolytic
activity. Overall, these data exposed an abnormal pattern of be-
havior in the dodecanoyl-based OAKs; namely, once activity had
emerged, it suddenly vanished despite a further increase in Q or
H or both. Moreover, it was unclear at this point why OAKs bear-
ing very similar HQ properties would display significantly differ-
ent activities. Clearly, the relatively higher H of a12 OAKs was
responsible, but to what extent? The following experiments
addressed these issues.
Organization in Solution
To probe the implication of aggregation among hydrophobic
OAKs, we investigated the light scattering properties of OAKs
in phosphate-buffered saline (PBS) at the range of concentra-
tions used for bioassays. As shown in Table S1, most dodeca-
noyl-based OAKs were found to aggregate at low micromolar
concentrations. To obtain preliminary information on the aggre-
gate form, two representative OAKs (displaying a critical
aggregate concentration [CAC] < 3 mM), composed of two and
eight a12 subunits, were analyzed under light microscopy at two
concentrations. As shown in Figure 2, theOAKsdisplayeddistinct
and concentration-independent shapes, suggesting the poten-
tial existence of at least two forms, each specific to an OAK
sequence. Conversely, none of the butyryl- or octanoyl-based
OAKs displayed a tendency for aggregation under these condi-
tions, indicating that the relatively weaker hydrophobic forces
of these OAKs were overcome by the positively charged lysine
residues positioned relatively close to one another.
Figure 3A shows the concentration-dependent light scattering
profile of a representative series of dodecanoyl-based OAKs de-
void of N-terminal acyl. The data indicate that long OAKs (>4
subunits) were in the highest aggregation state, with a CAC value
in the lowmicromolar range (estimated from the intersection with
the OAK concentration axis). The shorter OAKs did not display
aggregative properties, whereas the presence of an acyl at the
N terminus consistently aggravated aggregation (see Table S1).
These results suggested that aggregation in solution is linked
to poor (or lack of) antibacterial activity of hydrophobic OAKs.
Presumably, large supramolecular structures are prohibited from
reaching internal targets that might be located beyond the bac-
terial cell wall. This notion is experimentally supported by data ofChemistry & Biology 15, 354–362, April 2008 ª2008 Elsevier Ltd All rights reserved 355
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SAR Studies of OAKsMIC assays performed in the presence of EDTA (Figure 3B),
which increases external membrane permeability. The data
clearly show that formerly active compounds (those that were
active in the absence of EDTA) became 4- to 8-fold more active
in the presence of the cation chelator, while previously inactive
OAKs revealed potent activity (i.e., activity was enhanced by
up to more than 50-fold). Note that bacterial viability assessed
by performing CFU counts yielded 1.46 ± 0.01 3 109 CFU/ml
in the presence of 2 mM EDTA compared with 1.76 ± 0.05 3
109 CFU/ml in the absence of EDTA, indicating that EDTA alone
did not significantly interfere with normal bacterial growth (Mar-
ynka et al., 2007). Thus, this assay allows the distinction between
truly inactive OAKs (i.e., those that lack the HQ properties re-
quired for activity) and potentially active OAKs (i.e., the apparent
inactivity of which pertains to their self-assembly in solution and,
consequently, are excluded by the bacterial cell wall). The fact
that all aggregated a-OAKs displayed hemolytic activity (dis-
cussed below) provides further support for this view. In contrast,
antibacterial a-OAKs did not aggregate in solution.
Properties of b-OAKs
To overcome aggregation and its deleterious consequences, a
heptameric OAK was used as a reference compound for further
SAR investigations, as summarized in Table S2, while represen-
tative compounds are shown in Table 1. The rationale for select-
ing the heptamer is that this OAK reasonably represents com-
pounds bearing HQ properties, which, a priori, should endow
antibacterial activity; however, instead, they are inactive while
displaying high tendencies for aggregation and hemolysis. As
also shown in Figure 1, transition from a- to b-OAK (by deleting
internal acyl moities) bears the structural consequence of intro-
ducing a tandem lysine (KK) motif into the oligomer sequence.
Thus, deletion of three alternating acyls yielded the OAK
a12-3b12, the H of which was significantly reduced (from 50%
Figure 2. Light Microscope Images of OAK
Aggregates
Dry samples were solubilized in PBS and
examined under light microscope (phase con-
trastmode) 2–4 hr after preparation at room tempe-
rature. (A) C12K-1a12 (50 mM); (B) C12K-1a12 (500
mM); (C) C12K-7a12 (50 mM); (D) C12K-7a12 (500
mM). Scale bar, 10 mm.
to 40%), while maintaining the molecular
net-positive Q of the parent compound.
This simultaneously led to disaggregation
(CAC increased by >10-fold) and to po-
tent, nonhemolytic antibacterial activity.
Three derivatives of this particular OAK
(C12K-3b12, C8K-3b12, and K-3b12) that
differentially affected H and/or Q values
confirmed that high H can revert to
aggregated hemolytic compounds with
reduced antibacterial potency.
The remaining b-OAKs were designed
to assess the effect of gradual N-terminal
truncation of a12-3b12. Each truncation
step systematically included four derivatives (NC12K-nb12,
C12K-nb12, C8K-nb12, and K-nb12, i.e., a total of 12 compounds
where n can be 1, 2, or 3). A few b-OAKs displayed potent but un-
selective activity. This particularly contrasted with a-OAKs that
generated preferential potency against gram-negative bacteria.
The most minuscule OAK revealed by this study that displayed
potent activity against both bacterial species was C12K-1b12, in-
dicating that two dodecanoyl and three lysyl residues represent
just about the minimal structural requirement for potent, nonse-
lective cytotoxic properties.
In addition, a few b-OAKs seemed to hold promise for more
specific activity (e.g., NC12-2b12). Noteworthy is the fact that the
transition between these types of activities often relied onminute
differences (compare, for example, C12-2b12 and C8-2b12). The
mere four carbon difference in the N-terminal acyl was responsi-
ble for drastic differences in activity profile, suggesting practi-
cally endless possibilities for future, in-depth, and fine-tuning
investigations.
Finally, whereas a-OAKs were shown to maintain activity after
long exposures to plasma (Radzishevsky et al., 2007b), we in-
vestigated whether the presence of the KK motif—known as a
cleavage site for serine proteases, such as trypsin—might influ-
ence bioavailability. The effect of plasma over a typical b-OAK
(C12K-2b12) was compared with a conventional antimicrobial
peptide, K4S4(1-16). The compounds were preincubated in hu-
man plasma for various time periods prior to assessing their abil-
ity to inhibit growth of E. coli. As shown in Figure 4, under condi-
tions that inactivated the conventional peptide, the OAK was not
affected even after longer periods of preincubation.
Relationships between HQ Values
and Antibacterial Properties
The biophysical properties of the 103 compounds assessed
against E. coli and S. aureus are summarized in Figure 5 to356 Chemistry & Biology 15, 354–362, April 2008 ª2008 Elsevier Ltd All rights reserved
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SAR Studies of OAKshighlight the fact that they cover a wide range of Q (up to +11)
and of H (up to 60%) values. Three major trends emerged.
First, potent antibacterial activity (MIC%3.1 mM) requires a rel-
atively narrow yet specific window of HQ values, with little regard
for the OAK sequence (i.e., if it is an a- or b-OAK). These values
(mean and SD calculated from the H and Q values of the most
active OAKs) were: H = 50 ± 2 and Q = 6.5 ± 1.9 for E. coli;
H = 47.7 ± 7.4 and Q = 4 ± 1 for S. aureus. In support of this
view, Figure 5B depicts the influences of acyl length and number
of subunits on the MIC value of a representative series of OAKs.
Thus, Figure 5B, upper panel, shows that activity of butyryl-
based OAKs emerged upon attaining a certain HQ window
(with maximal activity at 12 mM). The same trend was observed
with octanoyl-based OAKs, but, bearing higher overall H, these
OAKs attained an improved MIC value (3.1 mM). A propos, note
that the longest derivative displayed a higher MIC value (reduced
potency). As for the dodecanoyl-based series, only the shortest
Figure 3. Relations between Self-Assembly
and Antibacterial Activity
(A) The dose-dependent light scattering of a repre-
sentative series of a-OAKs at the biologically rele-
vant concentration range. CAC was evaluated by
extrapolating the curve to the intercept with the
x axis.
(B) The MIC against E. coli when assessed in the
absence (white) or presence (gray) of EDTA. Aster-
isks indicate MIC > 50 mM. Error bars represent
±1 SD.
compound displayed some activity,
which disappeared in longer derivatives.
An overall similar trend was observed
with S. aureus (Figure 5B, lower panel,),
although OAKs of these series displayed
weakanti-Staphylococcal activity at best.
These data therefore suggested a rever-
sal trend that occurred beyond the opti-
mal HQ window. Under this assumption,
we interpret these results as if the short-
est dodecanoyl-based a-OAK was al-
ready beyond the optimal HQ window,
as discussed below. Also, the data from
Figure 5B points to the possibility that,
at Q% 5 and QR 6, active OAKs would
display genuine specificity for gram-pos-
itive or gram-negative bacteria. Support
for this view is provided by the fact that
a representative OAK from each group
displayed potent activity against a large
panel of gram-negative bacteria (Rad-
zishevsky et al., 2007b) and against a
large panel of Staphylococcal strains
(Table S3), respectively.
Second, aggregation in solution can
explain discrepancies, such as why the
‘‘active HQ window’’ contains inactive
OAKs (as depicted in Figure 3) or the fact
that most hemolytic OAKs displayed aweak antibacterial activity
(as discussed further below). This is not to say that all types of
aggregates are necessarily inactive, especially considering that
an aggregated compound can be inactive against one micro-
organism but active against another. An interesting example is
represented by previous findings showing that short and aggre-
gated dodecanoyl-based OAKs displayed potent antiplasmodial
properties at concentrations above the CAC values (Radzishev-
sky et al., 2007a), supporting the notion that interactions of ag-
gregates with eukaryotic (as opposed to prokaryotic) cells are
governed by different rules, if only due to lack of a cell wall.
Third, molecular H is often dictated by the nature of the N-ter-
minal residue. For instance, H values increased with increasing
number of subunits in OAKs that lack an N-terminal acyl (e.g.,
OAKs 41–49), unlike in the presence of octanoyl (OAKs 25–31)
or dodecanoyl (OAKs 32–40). This H stabilization enables to
focus on effects specific to Q upon subunit variations.Chemistry & Biology 15, 354–362, April 2008 ª2008 Elsevier Ltd All rights reserved 357
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SAR Studies of OAKsTable 1. Biophysical Properties of Representative b12-OAKs
No. OAK Sequencea Designation Qb % AcNc
MIC (mM)d
LC50 (mM)
e CAC (mM)fEc Sa
81 NH2lKlKlKlKlKlKlK 7a12 8 50.0 >50 >50 4.1 1.7 ± 0.5
84 NH2lKlKlKlKlKlKlK a12-3b12 8 39.5 25 >50 >100 >25
96 NH2l-KlK-KlK NC12-2b12 5 38.5 50 3.1 >100 >25
100 NH2lK-KlK a12-b12 4 38.9 >50 >50 >100 >25
a l, deleted aminododecanoyl residue; K, lysyl.
bMolecular charge in physiological conditions.
c Hydrophobicity measure, defined as the % acetonitrile eluent on a C18 HPLC column.
d Lowest OAK concentration that fully inhibited bacterial growth after 24 h culture at 37C. Ec, Escherichia coli; Sa, Staphylococcus aureus.
e OAK concentration that induced 50% hemolysis (1% hematocrit) after 3 hr incubation.
f Critical aggregate concentration, evaluated by linear extrapolation. Values represent the mean ± SD of at least two independent experiments.Relationships between HQ Values
and Hemolytic Activity
With the exception of three or four compounds, the vast majority
of the testedOAKswere revealed to belong to one of two groups:
nonaggregated (CAC > 25 mM) or aggregated (CAC < 25 mM)
compounds. The cut-off value of 25 mM was dictated by the
method used to estimate the CAC value, which, given the OAK
concentrations tested (100 mM and subsequent 2-fold dilutions),
required at least three data points of light scattered above linear-
ity (see, for example, Figure 3A). If one adopts this view, one can
see a clear relationship in Figure 6 between aggregation and
hemolytic activity. The fact that both occurred at high H (>45%)
regardless of Q (from+2 to +11) or sequence (a- and b-OAKs) im-
plicates hydrophobic forces in both aggregation and hemolysis.
From this point of view, the exceptions that displayed a tendency
for aggregation and a mild hemolytic activity are considered
borderline cases, the activity profiles of which probably reflect
differences in aggregate size and/or shape.
Circular dichroism (CD) measurements performed on a variety
of OAKs provided further insight into organizational properties.
The lower panels of Figure 6 summarize the outcome from two
series of representative OAKs selected to assess the effect of
acyl length and of sequence. As shown in Figure 6C, butyryl-
and octanoyl-based OAKs displayed characteristic CD profiles
of a random structure unlike the dodecanoyl-based OAK. Fig-
ure 6D also shows a nonrandom structure for the aggregated
7a12 but not for its derivative a12-3b12 (resulting from deletion358 Chemistry & Biology 15, 354–362, April 2008 ª2008 Elsevier Ltdof three internal acyls). Increasing H through N-terminus modifi-
cation increased aggregation and reverted to a nonrandom CD
profile. Clearly, the CD profile obtained for aggregates are not
of random structures, but rather resemble helical structures
(a helix, for instance, is characterized by a positive maximum
at 195 nm followed by double minima at 208 and 222 nm). These
results, combined with the fact that nonrandomCD profiles were
obtained only with aggregated OAKs, suggest that these
profiles reflect rather supramolecular organizations. To the best
of our knowledge, there are no CD studies relating to this phe-
nomenon, but we know from experience that certain highly orga-
nized self-assemblies can display CD profiles that resemble
those of classical a helix, b sheet, and others.
Thus, as previously observed with butyryl- and octanoyl-
based OAKs (Radzishevsky et al., 2007b), the present CD data
failed to detect a stable secondary structure in all analogous
OAKs in a variety of solvent systems, including in the presence
of various liposomal compositions (data not shown). With some
of the dodecanoyl-based OAKs, however, the data were unam-
biguous in demonstrating a CD profile reminiscent to that of he-
lical structures (Greenfield and Fasman, 1969). The strong corre-
lation existing between aggregated OAKs and hemolytic activity
provides strong support for the hypothesis underlying OAKs
design (Radzishevsky et al., 2007b), implying the possibility of
a link between stable folds (i.e., rigid structures) and hemolytic
properties of antimicrobial peptides. Accordingly, the data indi-
cate that incorporation of fatty acids within a peptide backboneFigure 4. Inactivation by Plasma
E. coli growth inhibitory activity of C12K-2b12 (A)
and a control peptide K4S4(1-16) (B) after various
preincubation periods with 50% human plasma.
Asterisks, control experiments (without plasma);
circles, squares, and triangles indicate preincuba-
tion of 3, 6, and 18 hr, respectively. Error bars
represent ± 1 SD.All rights reserved
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SAR Studies of OAKsFigure 5. Relationships between HQ Properties and Antibacterial Activity
(A) The HQmap of 103 OAKs. Numbers correspond to the sequences listed in Tables S1 and S2. Circles highlight the most potent OAKs (MIC% 3.1 mM) against
E. coli (upper panel; OAKs 36–39, 93, and 97) and S. aureus (lower panel; OAKs 96–98 and 101), respectively.
(B) The effects of subunits variations on the MIC value on E. coli (upper panel) and S. aureus (lower panel), respectively.can suppress the formation of a stable molecular fold if the acyl
chain is not too long (i.e., may be longer than 8 carbon atoms, but
must be shorter than 12). Conceivably, unlike short acyls, dodec-
anoyl residues are long enough to bend and create rigid amphi-
pathic structures. Figure 7 depicts a drawing of such potential
structures (stabilized primarily by hydrophobic interactions and
eventually by hydrogen bonds between backbone amides) that
can interact with RBC membrane and disrupt it—much as ob-
served with conventional amphipathic antimicrobial peptides
(Radzishevsky et al., 2005; Avrahami et al., 2001; Feder et al.,
2000).
In conclusion, this study establishes that dodecanoyl-based
OAKs differ from octanoyl- and butyryl-based OAKs in two re-
spects: self-assembly and activity spectrum. Thus, the acyl chain
length plays multiple and crucial roles in molecular organization
and in selective activity of OAKs. This study also unraveled min-
iature OAKs that displayed potent and broad-spectrum activity.
Some of these tiny OAKs may be difficult to use in systemic
therapeutic applications due to their anticipated toxicities (e.g.,
high hemolytic activity), but these simple and inexpensive com-Chemistry & Biologypounds could well be useful in other antibacterial applications,
such as in cosmetics, food, or pharmaceutical technologies
(Singh and Cameotra, 2004; Solans et al., 1989), and eventually
in topical treatments of resilient infections.
SIGNIFICANCE
The availability of new antimicrobial compounds that are de-
void of the limitations associated with current antibiotics is
much desired, and the concept of providing chemically and
metabolically stable, active compounds in order to achieve
enhanced specificity and bioavailability has been widely
acknowledged. Many designed AMPs have been presented,
including ones with pseudopeptidic or peptide-mimetic
structures, all touted as a novel potential new class of anti-
biotics. TheOAK class of antimicrobial peptides is, however,
quite an interesting family due to its simplicity: very few
building blocks and a flexible chain arrangement presenting
a novel intercalation of polar and hydrophobic residues, the
sequence of which can be made to vary in quasiunlimited15, 354–362, April 2008 ª2008 Elsevier Ltd All rights reserved 359
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SAR Studies of OAKsFigure 6. Hemolytic Activity and Organiza-
tion in Solution
Upper panels show the hemolytic activity of 103
OAKs plotted as a function of hydrophobicity (A)
or charge (B), while highlighting aggregative prop-
erties. Open circles (total of 76 OAKs) with CAC >
25 mM; closed circles (total of 27OAKs) with CAC<
25 mM. Error bars represent ± 1 SD. Lower panels
compare the circular dichroism spectra (100 mM in
PBS) of three representative a-OAKs (C) and of
three dodecanoyl-based a- and b-OAKs (D).
Figure 7. A Hypothetical Model for a12-Oaks Organization
Shown is a representative OAK dodecanoyl-lysyl-3a12 in its monomeric form (left) the acyl residues of which have folded to create an amphipathic structure that
can subsequently associate to form a dimer (right) or multimers (as shown in Figure 2). Such structures would be stabilized primarily by hydrophobic interactions
and eventually (if packed tightly enough) by hydrogen bonds between backbone amides within each molecule in a layer and/or between molecules of adjacent
layers.
alternatives. They seem to work very well as antimicrobials,
with a desirable set of characteristics (Radzishevsky et al.,
2007b). Moreover, the OAK concept is likely to lead to the
development of useful anti-infective agents, and could also
generate valuable scientific information along the way. The
simple molecules dealt with in this concept could also pro-
vide some clearer answers on specific aspects of AMPmode
of action. Namely, the design of OAKs is shown to provide an
efficient tool for dissecting the roles of two parameters be-
lieved to bemost crucial to activity of antimicrobial peptides:
hydrophobicity and charge. By analyzing a library of over 100
compounds, the data confirmed some of the claimed prom-
ises for the OAK concept. In addition, the library is shown to
include a wealth of bioactive OAKs, some of which can be
considered the tiniest, potent, antimi-
crobial peptide mimetics in the litera-
ture. Finally, the data also provide a ro-
bust basis, with practically endless
possibilities, for future, in-depth, and
fine-tuning investigations.
EXPERIMENTAL PROCEDURES
OAK Synthesis
The OAKs were synthesized by the solid-phase
method, applying the Fmoc active ester chemistry
(Fields and Noble, 1990). Fmoc-12-aminododecanoic acid, Fmoc-8-aminooc-
tanoic acid, Fmoc-g-aminobutyric acid, and Fmoc-amino acids were pur-
chased from Iris Biotech GmbH (Marktredwitz, Germany). 4-Methylbenzhy-
drylamine resin (Novabiochem, Darmstadt, Germany) was used to obtain
amidated OAKs. After synthesis, the 9-fluorenylmethoxy carbonyl was re-
moved from the N-terminal amino acid and theOAKwas cleaved from the resin
with a 95/5 (v/v) mixture of trifluoroacetic acid (TFA):H2O (20mg of resin-bound
OAK in a 1 ml mixture). The TFA was then evaporated, and the OAK was pre-
cipitated with ether followed by six cold ether washes. The crude OAKs were
extracted from the resin with 30% acetonitrile in water and purified to chro-
matographic homogeneity in the range of >95% by reverse-phase high-pres-
sure liquid chromatography (HPLC) and subjected tomass spectrometer anal-
ysis (Alliance-ZQWaters). HPLC runs were performed on preparative and then
on analytical C18 columns (Vydac) with a linear gradient of acetonitrile in water
(1%/min), with both solvents containing 0.1% TFA. OAKs were stocked as
lyophilized powder at 20C. Prior to being tested, fresh solutions were360 Chemistry & Biology 15, 354–362, April 2008 ª2008 Elsevier Ltd All rights reserved
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SAR Studies of OAKsprepared in water (mQ; Millipore), vortexed, sonicated, centrifuged, and then
diluted in the appropriate medium.
Antibacterial Assay
MICs were determined with the microdilution assay in sterilized 96 well plates,
as previously described (Radzishevsky et al., 2007b) with E. coli (ATCC 35218)
and methicillin-resistant S. aureus (CI 15903) in a final volume of 200 ml as
follows: bacteria were grown overnight in Luria-Bertani (LB) growth medium
(10 g/l trypton, 5 g/l yeast extract, 5 g/l NaCl [pH 7.4]) and diluted 10,000-
fold in growth medium. Stock solutions of the peptides were diluted 10-fold in
growth medium. A 100 ml aliquot of LB containing bacteria (2–43 105 CFU/ml)
was added to 100 ml of culture medium containing the test compound
(0–100 mM in serial 2-fold dilutions). Inhibition of proliferation was determined
by optical density measurements (620 nm) after incubation overnight at 37C.
Enhanced Outer-Membrane Permeability Assay
The importance of self-assembly on OAKs activity against E. coli ATCC 35218
was explored by performing MIC experiments in the presence of 2 mM EDTA
(Radzishevsky et al., 2005). Briefly, 1 M EDTA solution in water (pH 8.3) was
dissolved in LB medium to 4 mM, and this solution was used for dissolving
the OAKs. Growth inhibition was assessed essentially as described above.
Stability in 50% Plasma
Molecular integrity and bioavailability in plasma were essentially assessed as
previously described (Radzishevsky et al., 2005). Briefly, AMP or OAK were
dissolved in saline (0.9% NaCl) at an initial concentration of 64 times the
MIC value, then diluted 2-fold in fresh human plasma and preincubated at
37C. After incubation, each sample was subjected to serial 2-fold dilutions
in LB medium and the MIC determined on E. coli ATCC 35218. Statistical
data were obtained from at least two independent experiments performed in
duplicates.
Light Scattering
The OAKs aggregation properties were investigated by static light scattering
measurements on a Jobin-Yvon Horiba Fluorolog-3 with FluorEssence (Tan-
ford, 1980). OAKs at an initial concentration of 100 mMwere submitted to serial
2-fold dilutions down to 0.05 mM in PBS (10 mM sodium phosphate, 150 mM
NaCl [pH 7.3]) at room temperature, incubated for 2 hr, and light scattering was
evaluated by measuring the reflected light at an angle of 90, holding both the
excitation and the emission at 400 nm (1 nm slits). To describe the dependence
of scattered signal on OAK concentration, the intensity of scattered light (mean
value from at least two independent experiments) was plotted against total
OAK concentrations, and a linear regression analysis was performed on the
data at the concentration range close to the monomer-aggregate transition
zone. Since the light scattering signal is proportional to the number of aggre-
gatedmolecules and the size of the aggregate, the slope is indicative of the ag-
gregation tendency and reveals the aggregation properties, where a slope
value above unity indicates the presence of aggregative form. For aggregating
OAKs, the CAC was evaluated by extrapolating the curve to the intercept with
the x axis.
CD Experiments
CD spectra were recorded on a model J-810 spectropolarimeter (Jasco,
Tokyo, Japan) connected to a Jasco spectramanager, with a QSHellma quartz
cell of 2 mm path length at 25C between 190 and 250 nm at a scanning speed
of 50 nm/min. The CD spectrum was scanned for OAK samples (100 mM) that
were dissolved in PBS. Minor contributions of circular differential scattering
were eliminated by subtracting the CD spectrum of buffer without OAK.
Data values shown as mean residue molar ellipticity (degrees cm2 dmol1)
represent the averages of three separate recordings.
Hemolytic Assay
The OAKs potential to disrupt erythrocyte membrane was determined against
human RBCs in PBS. Human blood was rinsed three times in PBS by centrifu-
gation for 2min at 2003 g, and resuspended in PBS at 5%hematocrite. A 50 ml
suspension containing 2.5 3 108 RBC was added to test tubes containing
200 ml of OAKs solutions (serial 2-fold dilutions in PBS), PBS alone (for baseline
values), or distilled water (for 100% hemolysis). After 3 hr incubation at 37CChemistry & Biologunder agitation, samples were centrifuged, and hemolytic activity was deter-
mined as a function of hemoglobin leakage by measuring absorbance
(450 nm) of 200 ml of the supernatants.
SUPPLEMENTAL DATA
Supplemental Data include three tables and a Supplemental Reference
and are available with this article online at http://www.chembiol.com/cgi/
content/full/15/4/354/DC1/.
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